benzamide has been researched along with n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aron, AR; Brown, AK; De Shetler, N; Ghahremani, DG; Lee, B; London, ED; Mandelkern, MA; Monterosso, JR; Morgan, AT; Poldrack, RA; Robertson, CL; Tabibnia, G | 1 |
1 other study(ies) available for benzamide and n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide
Article | Year |
---|---|
Striatal dopamine D₂/D₃ receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans.
Topics: Adult; Benzamides; Corpus Striatum; Female; Fluorine Radioisotopes; Frontal Lobe; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Neural Inhibition; Neural Pathways; Positron-Emission Tomography; Psychomotor Performance; Pyrrolidines; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2012 |